ProPhase Labs Total Liabilities

ProPhase Labs (PRPH) currently reports a total liabilities of $61M as of June 2026. That compares with $31M in the prior-year period — up 97.7% year over year. Use the charts on this page to explore ProPhase Labs's total liabilities history and peer comparisons.

ProPhase Labs's total liabilities increased from $31M to $61M — a 97.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ProPhase Labs reported $61M in total liabilities as of June 2026. That compares with $31M in the prior-year period — up 97.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ProPhase Labs, and consider following PRPH for alerts when major investors trade the stock.

ProPhase Labs is classified in the Healthcare sector. On total liabilities, it currently shows $61M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRPH with unrelated industries.